LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,591,000 | -53.6% | 66,875 | -68.8% | 0.05% | -58.4% |
Q2 2016 | $3,428,000 | -25.4% | 214,229 | -2.5% | 0.12% | -25.1% |
Q1 2016 | $4,596,000 | -28.4% | 219,799 | -7.6% | 0.17% | -24.4% |
Q4 2015 | $6,423,000 | +8.8% | 237,889 | +12.0% | 0.22% | +20.8% |
Q3 2015 | $5,901,000 | +93.8% | 212,348 | +70.9% | 0.18% | +112.8% |
Q2 2015 | $3,045,000 | +17.5% | 124,217 | -12.3% | 0.09% | +16.2% |
Q1 2015 | $2,592,000 | -27.8% | 141,647 | -27.2% | 0.07% | -29.5% |
Q4 2014 | $3,590,000 | – | 194,578 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |